Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (471-480 of 941) with videos related to

Pageof 95
Sort By:
Cancer Research|November 1, 1993
Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinomaM E Gleave, J T Hsieh, H C Wu, et al.
Cancer Research|June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancerBoris A Hadaschik, Kaixin Zhang, Alan I So, et al.
BJU International|April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancerBoris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 17, 2023
A phase 1 study of an injectable lidocaine paste for spermatic cord block in men with chronic scrotal content painLuke D E Witherspoon, Claudia Kesch, Veronika Schmitt, et al.
Oncotarget|April 15, 2015
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancerMasaki Shiota, Jennifer L Bishop, Ario Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablationZhiqiang Zou, Wei Zhang, Denise Young, et al.
The Prostate|May 4, 2011
TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapseSophie Giusiano, Stéphane Garcia, Claudia Andrieu, et al.
Investigational New Drugs|December 19, 2017
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancerEvan Y Yu, Susan L Ellard, Sebastien J Hotte, et al.
Molecular Cancer Therapeutics|March 6, 2015
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and ChemotherapyBarbara Lelj-Garolla, Masafumi Kumano, Eliana Beraldi, et al.
Scientific Reports|February 25, 2025
Discrimination of inherent characteristics of susceptible and resistant strains of Anopheles gambiae by explainable artificial intelligence analysis of flight trajectoriesYasser M Qureshi, Vitaly Voloshin, Katherine Gleave, et al.
Pageof 95

Showing results (471-480 of 941) with videos related to

Sort By:
Pageof 95
Cancer Research|November 1, 1993
Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinomaM E Gleave, J T Hsieh, H C Wu, et al.
Cancer Research|June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancerBoris A Hadaschik, Kaixin Zhang, Alan I So, et al.
BJU International|April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancerBoris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 17, 2023
A phase 1 study of an injectable lidocaine paste for spermatic cord block in men with chronic scrotal content painLuke D E Witherspoon, Claudia Kesch, Veronika Schmitt, et al.
Oncotarget|April 15, 2015
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancerMasaki Shiota, Jennifer L Bishop, Ario Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablationZhiqiang Zou, Wei Zhang, Denise Young, et al.
The Prostate|May 4, 2011
TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapseSophie Giusiano, Stéphane Garcia, Claudia Andrieu, et al.
Investigational New Drugs|December 19, 2017
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancerEvan Y Yu, Susan L Ellard, Sebastien J Hotte, et al.
Molecular Cancer Therapeutics|March 6, 2015
Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and ChemotherapyBarbara Lelj-Garolla, Masafumi Kumano, Eliana Beraldi, et al.
Scientific Reports|February 25, 2025
Discrimination of inherent characteristics of susceptible and resistant strains of Anopheles gambiae by explainable artificial intelligence analysis of flight trajectoriesYasser M Qureshi, Vitaly Voloshin, Katherine Gleave, et al.
Pageof 95